A product from the sea
Following fifteen years of international scientific research by independent scientists from the Royal Melbourne Institute of Technology University, the goal of identifying the principal components responsible for the extract's high potency was achieved. The compounds were patented and trademarked, PCSO-524™ which is then formulated in to the product Lyprinol®. Most mussel powders over the years have shown conflicting results in efficacy studies due to the oxidation of their non-polar lipids (PCSO-524™) which is where their true activity lies. A patent was granted for the stabilisation of the mussel powder and also for the extraction process for PCSO-524®. Usage patents are also in place for its anti-inflammatory efficacy and other exciting applications for the formulated product Lyprinol®.
Marine Complex Lyprinol® is the formulated product containing the unique patented marine lipid group comprising a unique combination of different non-polar lipid groups and Omega-3 polyunsaturated fatty acids which are extracted from the New Zealand Green-Lipped Mussel (Perna canaliculus) along with pharmaceutical grade olive oil and d-alpha-tocopherol (vitamin E).
Many scientists and government institutions around the world agree that the average western diet is very high in another group of fatty acids, namely Omega-6's. As a result our cell membranes are unusually rich in precursors associated with inflammatory processes which can lead to arthritis, psoriasis and asthma, to name a few.
